Physician profile
Roham Rafat
NPI 1114246071
$2,357.58
in general payments reported to CMS, 2019-2025
14 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $294 · 2021: $203 · 2023: $327 · 2024: $577 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927 · Gift: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.93 |
| Gift | $239.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $906.67 | 2019-2025 | |
| Align Technology, INC. | $368.39 | 2019-2025 | Invisalign |
| Tulsa Dental Products LLC | $293.94 | 2020 | |
| Meisinger USA, LLC | $239.80 | 2024 | Utb24 |
| Nobel Biocare USA | $104.81 | 2019 | |
| Salvin Dental Specialties, INC. | $94.80 | 2021 | |
| Biohorizons Implant Systems INC. | $84.30 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Zimmer Biomet Holdings, INC. | $79.22 | 2019-2021 | |
| Solventum Corporation | $59.84 | 2024-2025 | 3m Scotchbond, Clarity Aligners, Relyx Unicem Aplicap |
| Dentsply Sirona INC | $44.64 | 2024 | Cerec |
| 3m Company | $38.15 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $15.00 | 2025 | |
| Southern Implants North America INC | $14.29 | 2023 | |
| Premier Dental Products Company | $13.73 | 2024 | Aeropro Cordless Handpiece |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roham Rafat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.